undamentalytics Newsletter
Sign in

Prime Medicine, Inc. balance sheet

At the end of fiscal 2025, Prime Medicine, Inc. had total assets of $343m, total liabilities of $222m and shareholders' equity of $121m. It held $63.0m in cash against $0 of debt: net cash of $63.0m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Cash and equivalents371851884218263
Total current assets—271297143212181
Total assets—302360194298343
Accounts payable—1420119
Deferred revenue (current)———078
Total current liabilities—5827563837
Total debt000000
Total liabilities—624461144222
Shareholders' equity2−156316133153121
Non-controlling interests and other (assets − liabilities − equity)—396————
Net debt (negative = net cash)−37−185−188−42−182−63
Shares outstanding———97m131m181m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: OCGN vs PRMEPRME vs TRDABOLT vs PRME

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Prime Medicine, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Prime Medicine, Inc.